1997 Buick LeSabre Limited
3.8 L • V6 • FWD • AT
1G4HR52K7VH554158
Sales history: 1
• $200Highlights
Condition
Run and drive
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
3.8 L • V6 • FWD • AT
Odometer
134,254 mi ≈ 216,060 km
Primary damage
Side
Docs
AL • Salvage
Extra
Auction
VIN
1G4HR52K7VH554158
Lot number
81648575
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Birmingham, AL
Description
Fuel type
Gasoline
Body color
Teal
Body type
Sedan
Generation
H-body
Trim
Limited
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Buick models
1997 Buick LeSabre Limited • 3.8 L • V6 • FWD • Automatic • Copart Lot: 81648575 • VIN: 1G4HR52K7VH554158
Find out more about this 1997 Buick LeSabre Limited, available at the Copart salvage car auction as lot 81648575 in Birmingham, AL. This car has Side main damage. It is listed with Run and drive start condition code. Odometer shows 134,254 mi. This Teal Buick LeSabre Sedan is equipped with Gasoline 3.8 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for 1G4HR52K7VH554158 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
